214 related articles for article (PubMed ID: 15566177)
1. Hypofractionation in non-small cell lung cancer (NSCLC): suggestions from modelling both acute and chronic hypoxia.
Ruggieri R
Phys Med Biol; 2004 Oct; 49(20):4811-23. PubMed ID: 15566177
[TBL] [Abstract][Full Text] [Related]
2. Computed 88% TCP dose for SBRT of NSCLC from tumour hypoxia modelling.
Ruggieri R; Stavreva N; Naccarato S; Stavrev P
Phys Med Biol; 2013 Jul; 58(13):4611-20. PubMed ID: 23771131
[TBL] [Abstract][Full Text] [Related]
3. Optimal fractionation in radiotherapy for non-small cell lung cancer--a modelling approach.
Lindblom E; Dasu A; Toma-Dasu I
Acta Oncol; 2015; 54(9):1592-8. PubMed ID: 26217986
[TBL] [Abstract][Full Text] [Related]
4. A modified hypoxia-based TCP model to investigate the clinical outcome of stereotactic hypofractionated regimes for early stage non-small-cell lung cancer (NSCLC).
Strigari L; Benassi M; Sarnelli A; Polico R; D'Andrea M
Med Phys; 2012 Jul; 39(7):4502-14. PubMed ID: 22830782
[TBL] [Abstract][Full Text] [Related]
5. The impact of hypofractionation on simultaneous dose-boosting to hypoxic tumor subvolumes.
Ruggieri R; Nahum AE
Med Phys; 2006 Nov; 33(11):4044-55. PubMed ID: 17153384
[TBL] [Abstract][Full Text] [Related]
6. Treatment fractionation for stereotactic radiotherapy of lung tumours: a modelling study of the influence of chronic and acute hypoxia on tumour control probability.
Lindblom E; Antonovic L; Dasu A; Lax I; Wersäll P; Toma-Dasu I
Radiat Oncol; 2014 Jun; 9():149. PubMed ID: 24974778
[TBL] [Abstract][Full Text] [Related]
7. Extending the linear-quadratic model for large fraction doses pertinent to stereotactic radiotherapy.
Guerrero M; Li XA
Phys Med Biol; 2004 Oct; 49(20):4825-35. PubMed ID: 15566178
[TBL] [Abstract][Full Text] [Related]
8. The modified linear-quadratic model of Guerrero and Li can be derived from a mechanistic basis and exhibits linear-quadratic-linear behaviour.
Carlone M; Wilkins D; Raaphorst P
Phys Med Biol; 2005 May; 50(10):L9-13; author reply L13-5. PubMed ID: 15876677
[No Abstract] [Full Text] [Related]
9. Severe hypofractionation: non-homogeneous tumour dose delivery can counteract tumour hypoxia.
Ruggieri R; Naccarato S; Nahum AE
Acta Oncol; 2010 Nov; 49(8):1304-14. PubMed ID: 20500031
[TBL] [Abstract][Full Text] [Related]
10. Radiation dose prescription for non-small-cell lung cancer according to normal tissue dose constraints: an in silico clinical trial.
van Baardwijk A; Bosmans G; Bentzen SM; Boersma L; Dekker A; Wanders R; Wouters BG; Lambin P; De Ruysscher D
Int J Radiat Oncol Biol Phys; 2008 Jul; 71(4):1103-10. PubMed ID: 18258382
[TBL] [Abstract][Full Text] [Related]
11. Impact of SBRT fractionation in hypoxia dose painting - Accounting for heterogeneous and dynamic tumor oxygenation.
Kjellsson Lindblom E; Ureba A; Dasu A; Wersäll P; Even AJG; van Elmpt W; Lambin P; Toma-Dasu I
Med Phys; 2019 May; 46(5):2512-2521. PubMed ID: 30924937
[TBL] [Abstract][Full Text] [Related]
12. Theoretical effectiveness of cell survival in fractionated radiotherapy with hypoxia-targeted dose escalation.
Chvetsov AV; Rajendran JG; Zeng J; Patel SA; Bowen SR; Kim EY
Med Phys; 2017 May; 44(5):1975-1982. PubMed ID: 28236652
[TBL] [Abstract][Full Text] [Related]
13. Relative clinical effectiveness of carbon ion radiotherapy: theoretical modelling for H&N tumours.
Antonovic L; Dasu A; Furusawa Y; Toma-Dasu I
J Radiat Res; 2015 Jul; 56(4):639-45. PubMed ID: 25858182
[TBL] [Abstract][Full Text] [Related]
14. A simple mathematical model of cyclic hypoxia and its impact on hypofractionated radiotherapy.
Taylor E
Med Phys; 2023 Mar; 50(3):1893-1904. PubMed ID: 36594511
[TBL] [Abstract][Full Text] [Related]
15. A treatment planning study evaluating a 'simultaneous integrated boost' technique for accelerated radiotherapy of stage III non-small cell lung cancer.
Dirkx ML; van Sörnsen De Koste JR; Senan S
Lung Cancer; 2004 Jul; 45(1):57-65. PubMed ID: 15196735
[TBL] [Abstract][Full Text] [Related]
16. Additional PET/CT in week 5-6 of radiotherapy for patients with stage III non-small cell lung cancer as a means of dose escalation planning?
Gillham C; Zips D; Pönisch F; Evers C; Enghardt W; Abolmaali N; Zöphel K; Appold S; Hölscher T; Steinbach J; Kotzerke J; Herrmann T; Baumann M
Radiother Oncol; 2008 Sep; 88(3):335-41. PubMed ID: 18514339
[TBL] [Abstract][Full Text] [Related]
17. Volume dependence in hypoxia-targeted dose escalation.
Chvetsov AV; Zeng J; Rajendran JG
Med Phys; 2018 Nov; 45(11):5325-5331. PubMed ID: 30192391
[TBL] [Abstract][Full Text] [Related]
18. Step and shoot IMRT to mobile targets and techniques to mitigate the interplay effect.
Ehler ED; Tomé WA
Phys Med Biol; 2009 Jul; 54(13):4311-24. PubMed ID: 19531851
[TBL] [Abstract][Full Text] [Related]
19. Tumour control in ion beam radiotherapy with different ions in the presence of hypoxia: an oxygen enhancement ratio model based on the microdosimetric kinetic model.
Strigari L; Torriani F; Manganaro L; Inaniwa T; Dalmasso F; Cirio R; Attili A
Phys Med Biol; 2018 Mar; 63(6):065012. PubMed ID: 28862152
[TBL] [Abstract][Full Text] [Related]
20. Modeling the Cellular Response of Lung Cancer to Radiation Therapy for a Broad Range of Fractionation Schedules.
Jeong J; Oh JH; Sonke JJ; Belderbos J; Bradley JD; Fontanella AN; Rao SS; Deasy JO
Clin Cancer Res; 2017 Sep; 23(18):5469-5479. PubMed ID: 28539466
[No Abstract] [Full Text] [Related]
[Next] [New Search]
